Literature DB >> 20564468

A homozygous SCN5A mutation in a severe, recessive type of cardiac conduction disease.

Axel Neu1, Michele Eiselt, Matthias Paul, Kathrin Sauter, Birgit Stallmeyer, Dirk Isbrandt, Eric Schulze-Bahr.   

Abstract

Cardiac sodium channels are key players in the generation and propagation of action potentials in the human heart. Heterozygous mutations in the SCN5A gene have been found to be associated with long QT syndrome, Brugada syndrome, and sinus node dysfunction (SND). Recently, overlapping arrhythmia phenotypes have been reported as well. Here we describe a novel recessive SCN5A mutation in a family originating from the German minority in White Russia. Four affected children with a history of early cardiac arrhythmia encompassing SND, conduction disease, and severe ventricular arrhythmias, are homozygous carriers of a novel SCN5A missense mutation (p.I230T) in the channel protein. Interestingly, the heterozygous mutation carriers had neither significant ECG abnormalities nor a history of cardiac events. Heterologous expression of SCN5A(I230T) channels revealed normal protein transport but altered biophysical sodium channel properties. Voltage range of both activation and inactivation were shifted in a way that resulted in decreased sodium current and loss of channel function. In conclusion, we describe a rare clinical condition with a novel SCN5A mutation causing a new type of complex cardiac arrhythmia. Unlike most previously reported sodium channelopathies, this overlap syndrome displays recessive inheritance characteristics and does not seem to follow simple Mendelian rules.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20564468     DOI: 10.1002/humu.21302

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  13 in total

1.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Back Sternick Eduardo; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong-Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti Mac Intyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Pablo Ochoa Juan; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  J Arrhythm       Date:  2022-05-31

2.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases.

Authors:  Arthur A M Wilde; Christopher Semsarian; Manlio F Márquez; Alireza Sepehri Shamloo; Michael J Ackerman; Euan A Ashley; Eduardo Back Sternick; Héctor Barajas-Martinez; Elijah R Behr; Connie R Bezzina; Jeroen Breckpot; Philippe Charron; Priya Chockalingam; Lia Crotti; Michael H Gollob; Steven Lubitz; Naomasa Makita; Seiko Ohno; Martín Ortiz-Genga; Luciana Sacilotto; Eric Schulze-Bahr; Wataru Shimizu; Nona Sotoodehnia; Rafik Tadros; James S Ware; David S Winlaw; Elizabeth S Kaufman; Takeshi Aiba; Andreas Bollmann; Jong Il Choi; Aarti Dalal; Francisco Darrieux; John Giudicessi; Mariana Guerchicoff; Kui Hong; Andrew D Krahn; Ciorsti MacIntyre; Judith A Mackall; Lluís Mont; Carlo Napolitano; Juan Pablo Ochoa; Petr Peichl; Alexandre C Pereira; Peter J Schwartz; Jon Skinner; Christoph Stellbrink; Jacob Tfelt-Hansen; Thomas Deneke
Journal:  Europace       Date:  2022-09-01       Impact factor: 5.486

Review 3.  The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology.

Authors:  Christiaan C Veerman; Arthur A M Wilde; Elisabeth M Lodder
Journal:  Gene       Date:  2015-09-08       Impact factor: 3.688

Review 4.  Brugada syndrome in children - Stepping into unchartered territory.

Authors:  Shashank P Behere; Steven N Weindling
Journal:  Ann Pediatr Cardiol       Date:  2017 Sep-Dec

5.  Switch From Fetal to Adult SCN5A Isoform in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Unmasks the Cellular Phenotype of a Conduction Disease-Causing Mutation.

Authors:  Christiaan C Veerman; Isabella Mengarelli; Elisabeth M Lodder; Georgios Kosmidis; Milena Bellin; Miao Zhang; Sven Dittmann; Kaomei Guan; Arthur A M Wilde; Eric Schulze-Bahr; Boris Greber; Connie R Bezzina; Arie O Verkerk
Journal:  J Am Heart Assoc       Date:  2017-07-24       Impact factor: 5.501

6.  Novel KLHL26 variant associated with a familial case of Ebstein's anomaly and left ventricular noncompaction.

Authors:  Sai Suma K Samudrala; Lauren M North; Karl D Stamm; Michael G Earing; Michele A Frommelt; Richard Willes; Swarnendu Tripathi; Nikita R Dsouza; Michael T Zimmermann; Donna K Mahnke; Huan Ling Liang; Michael Lund; Chien-Wei Lin; Gabrielle C Geddes; Michael E Mitchell; Aoy Tomita-Mitchell
Journal:  Mol Genet Genomic Med       Date:  2020-01-27       Impact factor: 2.183

7.  Protein structure aids predicting functional perturbation of missense variants in SCN5A and KCNQ1.

Authors:  Brett M Kroncke; Jeffrey Mendenhall; Derek K Smith; Charles R Sanders; John A Capra; Alfred L George; Jeffrey D Blume; Jens Meiler; Dan M Roden
Journal:  Comput Struct Biotechnol J       Date:  2019-02-01       Impact factor: 7.271

8.  A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.

Authors:  Sven Zumhagen; Marieke W Veldkamp; Birgit Stallmeyer; Antonius Baartscheer; Lars Eckardt; Matthias Paul; Carol Ann Remme; Zahurul A Bhuiyan; Connie R Bezzina; Eric Schulze-Bahr
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

9.  Whole-exome sequencing identifies Y1495X of SCN5A to be associated with familial conduction disease and sudden death.

Authors:  Zhi-Ping Tan; Li Xie; Yao Deng; Jin-Lan Chen; Wei-Zhi Zhang; Jian Wang; Jin-Fu Yang; Yi-Feng Yang
Journal:  Sci Rep       Date:  2014-07-10       Impact factor: 4.379

10.  Reevaluating the Mutation Classification in Genetic Studies of Bradycardia Using ACMG/AMP Variant Classification Framework.

Authors:  Liting Cheng; Xiaoyan Li; Lin Zhao; Zefeng Wang; Junmeng Zhang; Zhuo Liang; Yongquan Wu
Journal:  Int J Genomics       Date:  2020-02-25       Impact factor: 2.326

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.